CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering - CytoSorbents (NASDAQ:CTSO)

PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood

Related Keywords

United States ,Canada ,Canadian ,Cytosorbents Corporation ,Phillip Chan ,Kathleen Bloch ,Blood Institute ,Facebook ,Us Army ,National Heart ,Us Department Of Health ,Material Command ,Health Canada ,Bus Company Contact ,National Institutes Of Health ,Us Air ,European Union ,Human Services ,Chief Executive Officer ,Board Directors ,Sorbents Corporation ,Use Authorization ,Device Designations ,Timely Antithrombotic Removal Ticagrelor ,National Institutes ,Operations Command ,Air Force Material Command ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,